Objetivo
NAMDIATREAM will develop a cutting edge nanotechnology-based toolkit for multi-modal detection of biomarkers of most common cancer types and cancer metastases, permitting identification of cells indicative of early disease onset in a high-specificity and throughput format in clinical, laboratory and point-of-care devices. The project is built on the innovative concepts of super-sensitive and highly specific “lab-on-a-bead”, “lab-on-a-chip” and “lab-on-a-wire” nano-devices utilizing photoluminescent, plasmonic, magnetic and non-linear optical properties of nanomaterials. This offers groundbreaking advantages over present technologies in terms of stability, sensitivity, time of analysis, probe multiplexing, assay miniaturisation and reproducibility. The ETP in Nanomedicine documents point out that nanotechnology has yet to deliver practical solutions for the patients and clinicians in their struggle against common, socially and economically important diseases such as cancer. Over 3.2M new cases and 1.7M cancer-related deaths are registered in Europe every year, largely because diagnostic methods have an insufficient level of sensitivity, limiting their potential for early disease identification. We will deliver •Photoluminescent nanoparticle-based reagents and diagnostic chips for high throughput early diagnosis of cancer and treatment efficiency assessment •Nanocrystals enabling plasmon-optical and nonlinear optical monitoring of molecular receptors within body fluids or on the surface of cancer cell •Multi-Parameter screening of cancer biomarkers in diagnostic material implementing segmented magnetic nanowires •Validation of nano-tools for early diagnosis and highly improved specificity in cancer research. •OECD-compliant nanomaterials with improved stability, signal strength and biocompatibility Direct lead users of the results will be the diagnostic and medical imaging device companies involved in the consortium, clinical and academic partners
Ámbito científico
- engineering and technologyother engineering and technologiesmicrotechnologylab on a chip
- medical and health sciencesmedical biotechnologynanomedicine
- engineering and technologynanotechnologynano-materialsnanocrystals
- medical and health sciencesclinical medicineoncology
- engineering and technologymedical engineeringdiagnostic imaging
Tema(s)
Convocatoria de propuestas
FP7-NMP-2009-LARGE-3
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-IP - Large-scale integrating projectCoordinador
D02 CX56 Dublin
Irlanda
Ver en el mapa
Participantes (22)
La participación finalizó
20018 San Sebastian
Ver en el mapa
1210 Wien
Ver en el mapa
1211 Geneve
Ver en el mapa
35037 Marburg
Ver en el mapa
4 Dublin
Ver en el mapa
75654 Paris
Ver en el mapa
31077 Toulouse
Ver en el mapa
38106 Braunschweig
Ver en el mapa
1015 Lausanne
Ver en el mapa
73011 Chambery
Ver en el mapa
80539 Munchen
Ver en el mapa
38800 Le Pont De Claix
Ver en el mapa
94504 CHAMPIGNY SUR MARNE CEDEX
Ver en el mapa
48160 VIZCAYA BIZKAIA
Ver en el mapa
00131 Roma
Ver en el mapa
D12 EK79 Dublin
Ver en el mapa
NE2 4HH Newcastle upon Tyne
Ver en el mapa
SP4 7RT WILTSHIRE
Ver en el mapa
IP31 HF29 Cork
Ver en el mapa
01630 Saint Genis Pouilly
Ver en el mapa
55716 IDAR OBERSTEIN
Ver en el mapa
51100 Reims
Ver en el mapa